glp 1 agonist in heart failure GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Glucagon-Like Peptide 1 Receptor Agonists

Placental proinflammatory state and maternal endothelial dysfunction in preeclampsia

Ophthalmology 131(4):P87P133 Sharma N et al (2022) Fungal keratitis: a review of clinical presentations, treatment strategies and outcomes

This eliminates midday "brain fog" and restores the sharp focus required for a high-demand career in Memorial

Although no adverse pregnancy outcomes were reported in a study of Iranian women who took dehydrated garlic tablets (800 mg/day) for two months during the third trimester of pregnancy (153), the safety of garlic supplements in pregnancy has not been established

In light of this potential significant safety issue, the development of Lotiglipron has been discontinued, meaning the drug did not progress to further clinical trial stages to evaluate its efficacy and safety